Bio Tech/Life SciencesDefenseHealthtechHealth and wellnessB2B1-5 employees
Actively Raising
Female Founder
Female FounderAbout
GelSana Therapeutics is developing Cleragel, a next-generation wound dressing using proprietary polymer chemistry to address multiple wound healing challenges. The product provides drug-free inflammation control, repels bacteria, manages moisture balance, and evades foreign body reaction - all in a single biocompatible solution.
Traction & Metrics
Fundraising
$6.3M
Previous Round
Team
Products
Cleragel
Class I (510k-exempt) medical device coming to market Q1 2026.